{ "items" : [
    { "id" : "http://dbpedia.org/resource/Baxalta"
      "properties" : {
        "http://www.w3.org/2000/01/rdf-schema#comment" : [ "Baxalta (Bax, taken from its former parent company and Alta taken from the Latin Altus which translates as 'high' or 'profound') is a biopharmaceutical company founded on 1 July 2015 after its parent company, Baxter International, spun off biopharmaceutical division. valued at $6 billion." ] ,
        "http://xmlns.com/foaf/0.1/name" : [ "Baxalta" ] ,
        "http://xmlns.com/foaf/0.1/homepage" : [ "http://www.baxalta.com/" ] ,
        "http://dbpedia.org/ontology/foundingYear" : [ "2015Z" ] ,
        "http://dbpedia.org/ontology/industry" : [ "http://dbpedia.org/resource/Biotechnology" ] ,
        "http://dbpedia.org/ontology/keyPerson" : [ "http://dbpedia.org/resource/Chief_executive_officer",
          "http://dbpedia.org/resource/Chief_financial_officer",
          "http://dbpedia.org/resource/Ludwig_N._Hantson" ] ,
        "http://dbpedia.org/ontology/numberOfEmployees" : [ 16000 ] ,
        "http://dbpedia.org/ontology/product" : [ "http://dbpedia.org/resource/Hematology",
          "http://dbpedia.org/resource/Pulmonology",
          "http://dbpedia.org/resource/Immunology"] } } }
